±Û·çŸƼ¿Â ½ÃÀå : Á¦Ç° À¯Çü, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ªº°(ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«) : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2023-2030³â)
Glutathione Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030
»óǰÄÚµå
:
1446765
¸®¼Ä¡»ç
:
Persistence Market Research
¹ßÇàÀÏ
:
2024³â 01¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 190 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Persistence Market Research´Â ÃÖ±Ù ¼¼°è ±Û·çŸƼ¿Â ½ÃÀå¿¡ ´ëÇÑ ½ÉÃþ ºÐ¼®À» ¹ßÇ¥ÇÏ¿© ÁÖ¿ä ½ÃÀå ¿ªÇÐ, ¼ºÀå ÃËÁø¿äÀÎ ¹× °úÁ¦, ½ÅÈï µ¿Çâ¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ °³¿ä¸¦ Á¦°øÇß½À´Ï´Ù. ÀÌ º¸°í¼´Â ±Û·çŸƼ¿Â ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» Á¦°øÇϰí 2023³âºÎÅÍ 2030³â±îÁö ½ÃÀåÀÇ ¼ºÀå ±ËÀûÀ» ¿¹ÃøÇÏ´Â µ¶Á¡ µ¥ÀÌÅÍ¿Í Åë°è¸¦ Á¦½ÃÇÕ´Ï´Ù.
¼¼°è ±Û·çŸƼ¿Â ½ÃÀåÀº ¿¬Æò±Õ 8.7% ¼ºÀåÇÏ¿© 2023³â 4¾ï 7,000¸¸ ´Þ·¯¿¡¼ 2030³â ¸»¿¡´Â 8¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
±Û·çŸƼ¿Â ½ÃÀå ±Ô¸ð(2023E) : 4¾ï 7,000¸¸ ´Þ·¯
¿¹»ó ½ÃÀå °¡Ä¡(2030F) : 8¾ï 5,000¸¸ ´Þ·¯
¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2023-2030) : 8.7%.
°ú°Å ½ÃÀå ¼ºÀå·ü(2018-2022³â CAGR) : 8.1%.
±Û·çŸƼ¿Â ½ÃÀå - Á¶»ç ¹üÀ§
¾Æ¹Ì³ë»êÀÎ ±Û·çŸ¹Î»ê, ±Û¸®½Å, ½Ã½ºÅ×ÀÎÀ¸·Î ±¸¼ºµÈ Æ®¸®ÆéŸÀ̵åÀÎ ±Û·çŸƼ¿ÂÀº ü³»¿¡¼ Áß¿äÇÑ Ç×»êÈ ¹°Áú·Î ÀÛ¿ëÇÏ¿© Ȱ¼º»ê¼Ò·ÎºÎÅÍ º¸È£ÇÏ°í ´Ù¾çÇÑ »ý¸®±â´ÉÀ» Áö¿øÇÕ´Ï´Ù. ±Û·çŸƼ¿Â ¼ö¿ä´Â ³ëÈ ¹æÁö Á¦Ç°¿¡ ´ëÇÑ °ü½É Áõ°¡, ¿¹¹æÀû °Ç° °ü¸®, ¸¸¼º ÁúȯÀÇ ±ÞÁõ µîÀÇ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ±Û·çŸƼ¿ÂÀÇ Ç×»êÈ Æ¯¼ºÀº °£ ±â´É, »êÈ ½ºÆ®·¹½º °¨¼Ò, ÇØµ¶ ¹× ¸é¿ª ü°è °È¿¡ ÀáÀçÀûÀÎ ÀÌÁ¡ÀÌ ÀÖ¾î °Ç° ¹× À£ºù ºÐ¾ß¿¡¼ ÀαⰡ ÀÖ½À´Ï´Ù. °Ç° º¸Á¶ ½Äǰ ¹× °Ç° º¸Á¶ ½Äǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀåÀÇ ÃËÁø¿äÀÎ:
±Û·çŸƼ¿ÂÀÇ Ç×»êÈ Æ¯¼ºÀ¸·Î ÀÎÇØ ½ÄÀ½·á, ÀǾàǰ, ÈÀåǰ µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼ ±Û·çŸƼ¿ÂÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½Ä½À°ü ¹× ¹Ù»Û ¶óÀÌÇÁ½ºÅ¸ÀÏ·Î ÀÎÇØ ´ç´¢º´, ºñ¸¸, ÇǺΠÁúȯ µî ¼ÒºñÀÚ °ü·Ã ÁúȯÀÌ Áõ°¡ÇÏ¸é¼ ±Û·çŸƼ¿Â¿¡ ´ëÇÑ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. °Ç° ¹®Á¦¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ºñŸ¹Î¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ±Û·çŸƼ¿Â ½ÃÀå Á¡À¯À²À» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÇØµ¶ È¿°úµµ ¸ÅÃâ Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ºñ´©¿Í °°Àº ±Û·çŸƼ¿Â ±â¹Ý ÈÀåǰÀº ³ëÈ ¹æÁö, °í¸£Áö ¸øÇÑ ÇǺλö °³¼±, °Ç°ÇÏ°í ¹àÀº ÇǺθ¦ ÃËÁøÇÏ´Â µî ´Ù¾çÇÑ ¿ëµµ·Î Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. Àα¸ Áß ¿©¼º Àα¸ Áõ°¡´Â ±Û·çŸƼ¿Â ½ÃÀå È®´ëÀÇ Áß¿äÇÑ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :
±Û·çŸƼ¿Â ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎÀ¸·Î´Â ÁÖ¿ä Àç·á, ƯÈ÷ ȯ¿øÇü ¶Ç´Â »êÈÇü ±Û·çŸƼ¿ÂÀÇ ³ôÀº ºñ¿ëÀ¸·Î ÀÎÇØ »ý»ê ºñ¿ëÀÌ »ó½ÂÇϰí ÀÖ´Ù´Â Á¡À» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ °¢ Áö¿ªÀÇ »ç¿ë, Ç¥½Ã ¹× Á¦Á¶¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ Á¦¾àÀÌ ½ÃÀå È®´ë¸¦ Á¦ÇÑÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ƯÁ¤ Áúº´¿¡ ´ëÇÑ ±Û·çŸƼ¿ÂÀÇ È¿´ÉÀ» ÀÔÁõÇϱâ À§Çؼ´Â º¸´Ù ±¤¹üÀ§ÇÑ ÀÓ»ó½ÃÇèÀÌ ÇÊ¿äÇÕ´Ï´Ù. ±Û·çŸƼ¿Â º¸ÃæÁ¦°¡ Ç×»êÈ È¿°ú°¡ ÀÖÀ½¿¡µµ ºÒ±¸Çϰí, ±Û·çŸƼ¿Â º¸ÃæÁ¦°¡ ´Ù¾çÇÑ °Ç° »óŸ¦ È¿°úÀûÀ¸·Î ¿¹¹æÇϰųª Ä¡·áÇÒ ¼ö ÀÖ´ÂÁö¿¡ ´ëÇÑ µ¥ÀÌÅÍ´Â ÃæºÐÇÏÁö ¾Ê½À´Ï´Ù. ÇöÀç ÁøÇà ÁßÀÎ ¿¬±¸´Â ÀÌ·¯ÇÑ Áö½ÄÀÇ °ÝÂ÷¸¦ ÇØ¼ÒÇÏ°í °Ç° ÁõÁø¿¡ ´ëÇÑ ±Û·çŸƼ¿ÂÀÇ ÀáÀç·ÂÀ» ¹àÈ÷´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå ±âȸ :
±Û·çŸƼ¿Â ½ÃÀåÀÇ ±âȸ´Â ½ºÅ²ÄÉ¾î ¹× ÈÀåǰ ºÐ¾ß, ƯÈ÷ »êÈ ±Û·çŸƼ¿ÂÀÌ ÇÔÀ¯µÈ ·Î¼Ç, º¸½ÀÁ¦, ¾ÈƼ¿¡ÀÌ¡ Å©¸² µîÀÇ Á¦Ç°¿¡¼ ±Û·çŸƼ¿ÂÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â µ¥¼ ºñ·ÔµË´Ï´Ù. »ýȰ¼öÁØÀÇ Çâ»ó, °¡Ã³ºÐ ¼Òµæ Áõ°¡, ÀÏÇÏ´Â ¿©¼º Àα¸ Áõ°¡ µîÀÌ ¼ö¿äÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÈÀåǰ »ê¾÷ÀÌ ºü¸£°Ô ¼ºÀåÇÔ¿¡ µû¶ó ±Û·çŸƼ¿Â ½ÃÀåÀº ·Î¼Ç°ú Àڿܼ± Â÷´Ü Å©¸²À» Æ÷ÇÔÇÑ ÆÛ½º³ÎÄÉ¾î ¹× ÈÀåǰ Á¦Ç°¿¡ ±¤¹üÀ§ÇÏ°Ô »ç¿ëµÊÀ¸·Î½á ÀÌÀÍÀ» ¾òÀ» ¼ö Àִ ż¼¸¦ °®Ãß°í ÀÖ½À´Ï´Ù.
º» º¸°í¼¿¡¼ ´Ù·é ÁÖ¿ä Áú¹®µé
±Û·çŸƼ¿Â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
±Û·çŸƼ¿Â ¼ö¿ä¸¦ ÁÖµµÇÏ´Â »ê¾÷º° ¼ö¿ä´Â?
±â¼úÀÇ ¹ßÀüÀº ±Û·çŸƼ¿Â ½ÃÀå °æÀï ±¸µµ¸¦ ¾î¶»°Ô º¯È½Ã۰í Àִ°¡?
¼¼°è ±Û·çŸƼ¿Â ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?
¼¼°è ±Û·çŸƼ¿Â ½ÃÀåÀÇ »õ·Î¿î Æ®·»µå¿Í ¹Ì·¡ Àü¸ÁÀº?
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀå ¹üÀ§¿Í Á¤ÀÇ
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¼ºÀå ¾ïÁ¦¿äÀÎ
±âȸ
°úÁ¦
ÁÖ¿ä µ¿Çâ
Á¦Ç° À¯Çü ¼ö¸íÁֱ⠺м®
±Û·çŸƼ¿Â ½ÃÀå : ¹ë·ùüÀÎ
¿øÀç·á °ø±Þ¾÷ü ¸®½ºÆ®
Á¦Á¶¾÷ü ¸®½ºÆ®
À¯Åë¾÷ü ¸®½ºÆ®
¿ëµµ ¸®½ºÆ®
¼öÀͼº ºÐ¼®
Porter¡¯s Five Forces ºÐ¼®
ÁöÁ¤ÇÐÀû ±äÀå : ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ
°Å½Ã°æÁ¦Àû ¿äÀÎ
¼¼°èÀÇ ºÎ¹®º° Àü¸Á
¼¼°èÀÇ GDP ¼ºÀå·ü Àü¸Á
¼¼°èÀÇ »óÀ§ ½ÃÀå °³¿ä
¿¹Ãø ¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
±ÔÁ¦¿Í ±â¼ú »óȲ
Á¦3Àå ¼¼°èÀÇ ±Û·çŸƼ¿Â ½ÃÀå Àü¸Á : °ú°Å(2018-2022³â)¿Í ¿¹Ãø(2023-2030³â)
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
½ÃÀå ¼ö·®(À¯´Ö) ¿¹Ãø
½ÃÀå ±Ô¸ð¿Í Àü³â´ëºñ ¼ºÀå·ü
Àý´ëÀûÀÎ ±Ý¾× ±âȸ
½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø
°ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®, 2013-2016³â
ÇöÀç ½ÃÀå ±Ô¸ð ¿¹Ãø, 2018-2026³â
¼¼°èÀÇ ±Û·çŸƼ¿Â ½ÃÀå Àü¸Á : Á¦Ç° À¯Çü
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
Á¦Ç° À¯Çüº° °ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯) ¹× ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
Á¦Ç° À¯Çüº° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
Reduced Glutathione (GSH)
Oxidized Glutathione (GSSG)
Liposomal Glutathione
N-acetylcysteine (NAC)
S-Acetyl Glutathione
½ÃÀå ¸Å·Â ºÐ¼® : Á¦Ç° À¯Çü
¼¼°èÀÇ ±Û·çŸƼ¿Â ½ÃÀå Àü¸Á : Á¦Ç° ÇüÅÂ
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
Á¦Ç° Çüź° °ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
Á¦Ç° Çüź° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
°æ±¸ ĸ½¶ ¶Ç´Â Á¤Á¦
Æ®·ÎŰ
¾×ü
±Û·çŸƼ¿Â Á¤¸Æ³» Åõ¿©(IV)
±¹¼Ò Å©¸²
ÈíÀÔ
½ÃÀå ¸Å·Â ºÐ¼® : Á¦Ç° ÇüÅÂ
¼¼°èÀÇ ±Û·çŸƼ¿Â ½ÃÀå Àü¸Á : ÃÖÁ¾ ¿ëµµ
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
ÃÖÁ¾ ¿ëµµº° °ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯) ¹× ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
ÃÖÁ¾ ¿ëµµº° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
½ÄÀ̺¸ÃæÁ¦ ¹× ´ºÆ®¶ó½´Æ¼ÄÃ
½ºÅ²Äɾî
È£Èí±â °Ç°
Á¤¸Æ³»(IV) ¿ä¹ý
½ºÆ÷Ã÷ ¿µ¾çÇÐ
¸¸¼ºÁúȯ °ü¸®
ÈÀåǰ
½Äǰ º¸Á¸
ÀǾàǰ
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾ ¿ëµµ
Á¦4Àå ¼¼°èÀÇ ±Û·çŸƼ¿Â ½ÃÀå Àü¸Á : Áö¿ª
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
Áö¿ªº° °ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯) ¹× ¼ö·®(´ÜÀ§) ºÐ¼®, 2018³âºÎÅÍ 2022³â
ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í Áö¿ªº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
ºÏ¹Ì
À¯·´
µ¿¾Æ½Ã¾Æ
³²¾Æ½Ã¾Æ/¿À¼¼¾Æ´Ï¾Æ
¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ª
Á¦5Àå ºÏ¹ÌÀÇ ±Û·çŸƼ¿Â ½ÃÀå Àü¸Á : °ú°Å(2018³â-2022³â)¿Í ¿¹Ãø(2023³â-2030³â)
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
°¡°Ý ºÐ¼®
°ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ½ÃÀ庰 ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
±¹°¡º°
Á¦Ç° À¯Çüº°
Á¦Ç° Çüź°
ÃÖÁ¾ ¿ëµµº°
±¹°¡º° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
Á¦Ç° À¯Çüº° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
Reduced Glutathione (GSH)
Oxidized Glutathione (GSSG)
Liposomal Glutathione
N-acetylcysteine (NAC)
S-Acetyl Glutathione
Á¦Ç° Çüź° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
°æ±¸ ĸ½¶ ¶Ç´Â Á¤Á¦
Æ®·ÎŰ
¾×ü
±Û·çŸƼ¿Â Á¤¸Æ³» Åõ¿©(IV)
±¹¼Ò Å©¸²
ÈíÀÔ
ÃÖÁ¾ ¿ëµµº° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
½ÄÀ̺¸ÃæÁ¦ ¹× ´ºÆ®¶ó½´Æ¼ÄÃ
½ºÅ²Äɾî
È£Èí±â °Ç°
Á¤¸Æ³»(IV) ¿ä¹ý
½ºÆ÷Ã÷ ¿µ¾çÇÐ
¸¸¼ºÁúȯ °ü¸®
ÈÀåǰ
½Äǰ º¸Á¸
ÀǾàǰ
½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦6Àå À¯·´ÀÇ ±Û·çŸƼ¿Â ½ÃÀå Àü¸Á : °ú°Å(2018-2022³â)¿Í ¿¹Ãø(2023-2030³â)
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
°¡°Ý ºÐ¼®
°ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ½ÃÀ庰 ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
±¹°¡º°
Á¦Ç° À¯Çüº°
Á¦Ç° Çüź°
ÃÖÁ¾ ¿ëµµº°
±¹°¡º° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
µ¶ÀÏ
ÇÁ¶û½º
¿µ±¹
ÀÌÅ»¸®¾Æ
½ºÆäÀÎ
·¯½Ã¾Æ
Æ¢¸£Å°¿¹
±âŸ À¯·´
Á¦Ç° À¯Çüº° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
Reduced Glutathione (GSH)
Oxidized Glutathione (GSSG)
Liposomal Glutathione
N-acetylcysteine (NAC)
S-Acetyl Glutathione
Á¦Ç° Çüź° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
°æ±¸ ĸ½¶ ¶Ç´Â Á¤Á¦
Æ®·ÎŰ
¾×ü
±Û·çŸƼ¿Â Á¤¸Æ³» Åõ¿©(IV)
±¹¼Ò Å©¸²
ÈíÀÔ
ÃÖÁ¾ ¿ëµµº° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
½ÄÀ̺¸ÃæÁ¦ ¹× ´ºÆ®¶ó½´Æ¼ÄÃ
½ºÅ²Äɾî
È£Èí±â °Ç°
Á¤¸Æ³»(IV) ¿ä¹ý
½ºÆ÷Ã÷ ¿µ¾çÇÐ
¸¸¼ºÁúȯ °ü¸®
ÈÀåǰ
½Äǰ º¸Á¸
ÀǾàǰ
½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦7Àå µ¿¾Æ½Ã¾ÆÀÇ ±Û·çŸƼ¿Â ½ÃÀå Àü¸Á : °ú°Å(2018-2022³â)¿Í ¿¹Ãø(2023-2030³â)
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
°¡°Ý ºÐ¼®
°ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ½ÃÀ庰 ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
±¹°¡º°
Á¦Ç° À¯Çüº°
Á¦Ç° Çüź°
ÃÖÁ¾ ¿ëµµº°
±¹°¡º° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
Á¦Ç° À¯Çüº° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
Reduced Glutathione (GSH)
Oxidized Glutathione (GSSG)
Liposomal Glutathione
N-acetylcysteine (NAC)
S-Acetyl Glutathione
Á¦Ç° Çüź° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
°æ±¸ ĸ½¶ ¶Ç´Â Á¤Á¦
Æ®·ÎŰ
¾×ü
±Û·çŸƼ¿Â Á¤¸Æ³» Åõ¿©(IV)
±¹¼Ò Å©¸²
ÈíÀÔ
ÃÖÁ¾ ¿ëµµº° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
½ÄÀ̺¸ÃæÁ¦ ¹× ´ºÆ®¶ó½´Æ¼ÄÃ
½ºÅ²Äɾî
È£Èí±â °Ç°
Á¤¸Æ³»(IV) ¿ä¹ý
½ºÆ÷Ã÷ ¿µ¾çÇÐ
¸¸¼ºÁúȯ °ü¸®
ÈÀåǰ
½Äǰ º¸Á¸
ÀǾàǰ
½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦8Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ ±Û·çŸƼ¿Â ½ÃÀå Àü¸Á : °ú°Å(2018-2022³â) ¹× ¿¹Ãø(2023-2030³â)
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
°¡°Ý ºÐ¼®
°ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ½ÃÀ庰 ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
±¹°¡º°
Á¦Ç° À¯Çüº°
Á¦Ç° Çüź°
ÃÖÁ¾ ¿ëµµº°
±¹°¡º° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
Àεµ
µ¿³²¾Æ½Ã¾Æ
´ºÁú·£µå
³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾Æ ±âŸ Áö¿ª
Á¦Ç° À¯Çüº° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
Reduced Glutathione (GSH)
Oxidized Glutathione (GSSG)
Liposomal Glutathione
N-acetylcysteine (NAC)
S-Acetyl Glutathione
Á¦Ç° Çüź° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
°æ±¸ ĸ½¶ ¶Ç´Â Á¤Á¦
Æ®·ÎŰ
¾×ü
±Û·çŸƼ¿Â Á¤¸Æ³» Åõ¿©(IV)
±¹¼Ò Å©¸²
ÈíÀÔ
ÃÖÁ¾ ¿ëµµº° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
½ÄÀ̺¸ÃæÁ¦ ¹× ´ºÆ®¶ó½´Æ¼ÄÃ
½ºÅ²Äɾî
È£Èí±â °Ç°
Á¤¸Æ³»(IV) ¿ä¹ý
½ºÆ÷Ã÷ ¿µ¾çÇÐ
¸¸¼ºÁúȯ °ü¸®
ÈÀåǰ
½Äǰ º¸Á¸
ÀǾàǰ
½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦9Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ±Û·çŸƼ¿Â ½ÃÀå Àü¸Á : °ú°Å(2018³â-2022³â)¿Í ¿¹Ãø(2023³â-2030³â)
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
°¡°Ý ºÐ¼®
°ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ½ÃÀ庰 ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
±¹°¡º°
Á¦Ç° À¯Çüº°
Á¦Ç° Çüź°
ÃÖÁ¾ ¿ëµµº°
±¹°¡º° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
ºê¶óÁú
¸ß½ÃÄÚ
±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
Á¦Ç° À¯Çüº° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
Reduced Glutathione (GSH)
Oxidized Glutathione (GSSG)
Liposomal Glutathione
N-acetylcysteine (NAC)
S-Acetyl Glutathione
Á¦Ç° Çüź° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
°æ±¸ ĸ½¶ ¶Ç´Â Á¤Á¦
Æ®·ÎŰ
¾×ü
±Û·çŸƼ¿Â Á¤¸Æ³» Åõ¿©(IV)
±¹¼Ò Å©¸²
ÈíÀÔ
ÃÖÁ¾ ¿ëµµº° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
½ÄÀ̺¸ÃæÁ¦ ¹× ´ºÆ®¶ó½´Æ¼ÄÃ
½ºÅ²Äɾî
È£Èí±â °Ç°
Á¤¸Æ³»(IV) ¿ä¹ý
½ºÆ÷Ã÷ ¿µ¾çÇÐ
¸¸¼ºÁúȯ °ü¸®
ÈÀåǰ
½Äǰ º¸Á¸
ÀǾàǰ
½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ±Û·çŸƼ¿Â ½ÃÀå Àü¸Á : °ú°Å(2018-2022³â)¿Í ¿¹Ãø(2023-2030³â)
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
°¡°Ý ºÐ¼®
°ú°Å ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ½ÃÀ庰 ¼ö·®(´ÜÀ§) ºÐ¼®, 2018-2022³â
±¹°¡º°
Á¦Ç° À¯Çüº°
Á¦Ç° Çüź°
ÃÖÁ¾ ¿ëµµº°
±¹°¡º° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
GCC
ÀÌÁýÆ®
³²¾ÆÇÁ¸®Ä«°øÈ±¹
ºÏ¾ÆÇÁ¸®Ä«
±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦Ç° À¯Çüº° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
Reduced Glutathione (GSH)
Oxidized Glutathione (GSSG)
Liposomal Glutathione
N-acetylcysteine (NAC)
S-Acetyl Glutathione
Á¦Ç° Çüź° ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
°æ±¸ ĸ½¶ ¶Ç´Â Á¤Á¦
Æ®·ÎŰ
¾×ü
±Û·çŸƼ¿Â Á¤¸Æ³» Åõ¿©(IV)
±¹¼Ò Å©¸²
ÈíÀÔ
ÇöÀç ½ÃÀå ±Ô¸ð(¸¸ ´Þ·¯)¿Í ÃÖÁ¾ ¿ëµµº° ¼ö·®(´ÜÀ§) ¿¹Ãø, 2023-2030³â
½ÄÀ̺¸ÃæÁ¦ ¹× ´ºÆ®¶ó½´Æ¼ÄÃ
½ºÅ²Äɾî
È£Èí±â °Ç°
Á¤¸Æ³»(IV) ¿ä¹ý
½ºÆ÷Ã÷ ¿µ¾çÇÐ
¸¸¼ºÁúȯ °ü¸®
ÈÀåǰ
½Äǰ º¸Á¸
ÀǾàǰ
½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦11Àå °æÀï ±¸µµ
½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â
½ÃÀå ±¸Á¶
½ÃÀ庰 °æÀïµµ ¸ÅÇÎ
°æÀï ¾Æ³¯·Î±× IC
º¸ÀÌ´Â Á¦Ç° À¯Çü ¿ë·®
±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
Kyowa Hakko Bio Co., Ltd.
Shandong Jincheng Bio-pharmaceutical Co., Ltd.
KOHJIN Life Sciences
Now Foods
Mitsubishi Corporation Life Science Limited
Bachem
Lypo-Spheric
Ajinomoto Group
Atrium Innovations
Á¦12Àå ºÎ·Ï
Á¶»ç ¹æ¹ý
Á¶»ç °¡Á¤
µÎÀÚ¾î ¹× ¾à¾î
LSH
¿µ¹® ¸ñÂ÷
Persistence Market Research has recently published an in-depth analysis of the global Glutathione Market, offering a comprehensive overview of key market dynamics, growth drivers, challenges, and emerging trends. This report provides valuable insights into the structure of the Glutathione Market, presenting exclusive data and statistics that forecast the market's growth trajectory from 2023 to 2030.
The global glutathione market is projected to grow at a compound annual growth rate (CAGR) of 8.7%, reaching a value of US$0.85 billion by the conclusion of 2030, up from US$0.47 billion in 2023.
Key Insights:
Glutathione Market Size (2023E): US$0.47 Bn
Projected Market Value (2030F): US$0.85 Bn
Global Market Growth Rate (CAGR 2023 to 2030): 8.7%
Historical Market Growth Rate (CAGR 2018 to 2022): 8.1%
Glutathione Market- Report Scope:
Glutathione, a tripeptide formed by amino acids glutamic acid, glycine, and cysteine, acts as a vital antioxidant in the body, protecting against reactive oxygen species and supporting various physiological functions. Its demand is driven by factors such as the rising interest in anti-aging products, preventative healthcare, and the surge in chronic diseases. Glutathione's antioxidant properties make it popular in the health and wellness sector, with potential benefits for liver function, oxidative stress reduction, detoxification, and immune system enhancement. The growing demand for nutraceuticals and health supplements further fuels the market's growth.
Market Growth Drivers:
The increasing utilization of glutathione in various sectors, including food & beverage, pharmaceuticals, and cosmetics, is propelled by its antioxidant properties. The rise in consumer-related ailments like diabetes, obesity, and skin disorders, attributed to poor dietary habits and hectic lifestyles, is driving the demand for glutathione. As awareness of health issues grows, there is a heightened need for vitamins, boosting glutathione's market share. Detoxification benefits further contribute to increased sales. Glutathione-based cosmetics, such as soaps, are gaining traction due to their diverse applications, offering benefits like age repair, addressing uneven skin tone, and promoting healthier, brighter skin. The growing number of females in the population is a significant factor driving the expansion of the glutathione market.
Market Restraints:
Market restraints for glutathione include the high cost of key materials, particularly reduced or oxidized glutathione, driving production expenses. Strict regulatory constraints on usage, labeling, and manufacturing in different regions are anticipated to limit market expansion. Additionally, there is a need for more extensive clinical trials to establish the efficacy of glutathione for specific illnesses. Despite its recognized antioxidant properties, there is insufficient data to confirm whether glutathione supplements can effectively prevent or treat various health conditions. Ongoing research aims to fill these knowledge gaps and clarify glutathione's potential in promoting health.
Market Opportunities:
Opportunities in the glutathione market stem from its increasing adoption in the skincare and cosmetics sector, particularly in products like lotions, moisturizers, and anti-aging creams containing oxidized glutathione. The demand is driven by factors such as rising living standards, disposable incomes, and the growing population of working women. As the cosmetics industry continues to expand rapidly, the glutathione market is poised to benefit from its widespread use in personal care and cosmetic products, including lotions and sun creams.
Key Questions Answered in the Report:
What are the key factors driving the growth of the glutathione market?
Which industry verticals are driving the demand for glutathione?
How are technological advancements reshaping the competitive landscape of the glutathione market?
Who are the leading players in the global glutathione market?
What are the emerging trends and future prospects in the global glutathione market?
Competitive Intelligence and Business Strategy:
Prominent players in the global glutathione agarose resin market, including Kyowa Hakko Bio Co., Ltd., KOHJIN Life Sciences, Now Foods, and Mitsubishi Corporation Life Science Limited, are actively launching innovative projects to enhance their product offerings. The industry is characterized by a continuous focus on developing inventive and productive goods to strengthen global market positions. Ongoing innovations in this field present opportunities for both new entrants and established players throughout the forecast period. The high demand for affinity resin has led to the entry of new producers, while established firms are expanding into newer markets to secure larger market shares. Diversifying product portfolios is a key strategy for market leaders to meet the growing demand and maintain a competitive edge.
Key Companies Profiled:
Kyowa Hakko Bio Co., Ltd.
Shandong Jincheng Bio-pharmaceutical Co., Ltd.
KOHJIN Life Sciences
Now Foods
Mitsubishi Corporation Life Science Limited
Bachem
Lypo-Spheric
Ajinomoto Group
Atrium Innovations
Glutathione Market Segmentation:
By Product Type:
Reduced Glutathione (GSH)
Oxidized Glutathione (GSSG)
Liposomal Glutathione
N-acetylcysteine (NAC)
S-Acetyl Glutathione
By Product Form:
Oral Capsules or Tablets
Lozenges
Liquids
Intravenous (IV) Glutathione
Topical Creams
Inhalation
By End-use Application:
Nutritional Supplements/ Nutraceutical Supplements
Skin Care
Respiratory Health
Intravenous (IV) Therapy
Sports Nutrition
Chronic Illness Management
Cosmetics
Food Preservation
Pharmaceuticals
By Region:
North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa
Table of Contents
1. Executive Summary
1.1. Global Glutathione Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Type Lifecycle Analysis
2.4. Glutathione Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Glutathione Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Glutathione Market Outlook: Product Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
3.3.3.1. Reduced Glutathione (GSH)
3.3.3.2. Oxidized Glutathione (GSSG)
3.3.3.3. Liposomal Glutathione
3.3.3.4. N-acetylcysteine (NAC)
3.3.3.5. S-Acetyl Glutathione
3.4. Market Attractiveness Analysis: Product Type
3.5. Global Glutathione Market Outlook: Product Form
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Form, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Form, 2023 - 2030
3.5.3.1. Oral Capsules or Tablets
3.5.3.2. Lozenges
3.5.3.3. Liquids
3.5.3.4. Intravenous (IV) Glutathione
3.5.3.5. Topical Creams
3.5.3.6. Inhalation
3.6. Market Attractiveness Analysis: Product Form
3.7. Global Glutathione Market Outlook: End-use Application
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End-use Application, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use Application, 2023 - 2030
3.7.3.1. Nutritional Supplements/ Nutraceutical Supplements
3.7.3.2. Skin Care
3.7.3.3. Respiratory Health
3.7.3.4. Intravenous (IV) Therapy
3.7.3.5. Sports Nutrition
3.7.3.6. Chronic Illness Management
3.7.3.7. Cosmetics
3.7.3.8. Food Preservation
3.7.3.9. Pharmaceuticals
3.8. Market Attractiveness Analysis: End-use Application
4. Global Glutathione Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Glutathione Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Product Type
5.3.3. By Product Form
5.3.4. By End-use Application
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
5.5.1. Reduced Glutathione (GSH)
5.5.2. Oxidized Glutathione (GSSG)
5.5.3. Liposomal Glutathione
5.5.4. N-acetylcysteine (NAC)
5.5.5. S-Acetyl Glutathione
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Form, 2023 - 2030
5.6.1. Oral Capsules or Tablets
5.6.2. Lozenges
5.6.3. Liquids
5.6.4. Intravenous (IV) Glutathione
5.6.5. Topical Creams
5.6.6. Inhalation
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use Application, 2023 - 2030
5.7.1. Nutritional Supplements/ Nutraceutical Supplements
5.7.2. Skin Care
5.7.3. Respiratory Health
5.7.4. Intravenous (IV) Therapy
5.7.5. Sports Nutrition
5.7.6. Chronic Illness Management
5.7.7. Cosmetics
5.7.8. Food Preservation
5.7.9. Pharmaceuticals
5.8. Market Attractiveness Analysis
6. Europe Glutathione Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Product Type
6.3.3. By Product Form
6.3.4. By End-use Application
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
6.5.1. Reduced Glutathione (GSH)
6.5.2. Oxidized Glutathione (GSSG)
6.5.3. Liposomal Glutathione
6.5.4. N-acetylcysteine (NAC)
6.5.5. S-Acetyl Glutathione
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Form, 2023 - 2030
6.6.1. Oral Capsules or Tablets
6.6.2. Lozenges
6.6.3. Liquids
6.6.4. Intravenous (IV) Glutathione
6.6.5. Topical Creams
6.6.6. Inhalation
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use Application, 2023 - 2030
6.7.1. Nutritional Supplements/ Nutraceutical Supplements
6.7.2. Skin Care
6.7.3. Respiratory Health
6.7.4. Intravenous (IV) Therapy
6.7.5. Sports Nutrition
6.7.6. Chronic Illness Management
6.7.7. Cosmetics
6.7.8. Food Preservation
6.7.9. Pharmaceuticals
6.8. Market Attractiveness Analysis
7. East Asia Glutathione Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Product Type
7.3.3. By Product Form
7.3.4. By End-use Application
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
7.5.1. Reduced Glutathione (GSH)
7.5.2. Oxidized Glutathione (GSSG)
7.5.3. Liposomal Glutathione
7.5.4. N-acetylcysteine (NAC)
7.5.5. S-Acetyl Glutathione
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Form, 2023 - 2030
7.6.1. Oral Capsules or Tablets
7.6.2. Lozenges
7.6.3. Liquids
7.6.4. Intravenous (IV) Glutathione
7.6.5. Topical Creams
7.6.6. Inhalation
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use Application, 2023 - 2030
7.7.1. Nutritional Supplements/ Nutraceutical Supplements
7.7.2. Skin Care
7.7.3. Respiratory Health
7.7.4. Intravenous (IV) Therapy
7.7.5. Sports Nutrition
7.7.6. Chronic Illness Management
7.7.7. Cosmetics
7.7.8. Food Preservation
7.7.9. Pharmaceuticals
7.8. Market Attractiveness Analysis
8. South Asia & Oceania Glutathione Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By Product Form
8.3.4. By End-use Application
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
8.5.1. Reduced Glutathione (GSH)
8.5.2. Oxidized Glutathione (GSSG)
8.5.3. Liposomal Glutathione
8.5.4. N-acetylcysteine (NAC)
8.5.5. S-Acetyl Glutathione
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Form, 2023 - 2030
8.6.1. Oral Capsules or Tablets
8.6.2. Lozenges
8.6.3. Liquids
8.6.4. Intravenous (IV) Glutathione
8.6.5. Topical Creams
8.6.6. Inhalation
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use Application, 2023 - 2030
8.7.1. Nutritional Supplements/ Nutraceutical Supplements
8.7.2. Skin Care
8.7.3. Respiratory Health
8.7.4. Intravenous (IV) Therapy
8.7.5. Sports Nutrition
8.7.6. Chronic Illness Management
8.7.7. Cosmetics
8.7.8. Food Preservation
8.7.9. Pharmaceuticals
8.8. Market Attractiveness Analysis
9. Latin America Glutathione Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Product Form
9.3.4. By End-use Application
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
9.5.1. Reduced Glutathione (GSH)
9.5.2. Oxidized Glutathione (GSSG)
9.5.3. Liposomal Glutathione
9.5.4. N-acetylcysteine (NAC)
9.5.5. S-Acetyl Glutathione
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Form, 2023 - 2030
9.6.1. Oral Capsules or Tablets
9.6.2. Lozenges
9.6.3. Liquids
9.6.4. Intravenous (IV) Glutathione
9.6.5. Topical Creams
9.6.6. Inhalation
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use Application, 2023 - 2030
9.7.1. Nutritional Supplements/ Nutraceutical Supplements
9.7.2. Skin Care
9.7.3. Respiratory Health
9.7.4. Intravenous (IV) Therapy
9.7.5. Sports Nutrition
9.7.6. Chronic Illness Management
9.7.7. Cosmetics
9.7.8. Food Preservation
9.7.9. Pharmaceuticals
9.8. Market Attractiveness Analysis
10. Middle East & Africa Glutathione Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Product Form
10.3.4. By End-use Application
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
10.5.1. Reduced Glutathione (GSH)
10.5.2. Oxidized Glutathione (GSSG)
10.5.3. Liposomal Glutathione
10.5.4. N-acetylcysteine (NAC)
10.5.5. S-Acetyl Glutathione
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Form, 2023 - 2030
10.6.1. Oral Capsules or Tablets
10.6.2. Lozenges
10.6.3. Liquids
10.6.4. Intravenous (IV) Glutathione
10.6.5. Topical Creams
10.6.6. Inhalation
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use Application, 2023 - 2030
10.7.1. Nutritional Supplements/ Nutraceutical Supplements
10.7.2. Skin Care
10.7.3. Respiratory Health
10.7.4. Intravenous (IV) Therapy
10.7.5. Sports Nutrition
10.7.6. Chronic Illness Management
10.7.7. Cosmetics
10.7.8. Food Preservation
10.7.9. Pharmaceuticals
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Analog IC
11.2.3. Apparent Product Type Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Kyowa Hakko Bio Co., Ltd.
11.3.1.1. Overview
11.3.1.2. Segments and Product Type
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Shandong Jincheng Bio-pharmaceutical Co., Ltd.
11.3.2.1. Overview
11.3.2.2. Segments and Product Type
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. KOHJIN Life Sciences
11.3.3.1. Overview
11.3.3.2. Segments and Product Type
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Now Foods
11.3.4.1. Overview
11.3.4.2. Segments and Product Type
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Mitsubishi Corporation Life Science Limited
11.3.5.1. Overview
11.3.5.2. Segments and Product Type
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Bachem
11.3.6.1. Overview
11.3.6.2. Segments and Product Type
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Lypo-Spheric
11.3.7.1. Overview
11.3.7.2. Segments and Product Type
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Ajinomoto Group
11.3.8.1. Overview
11.3.8.2. Segments and Product Type
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Atrium Innovations
11.3.9.1. Overview
11.3.9.2. Segments and Product Type
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
°ü·ÃÀÚ·á